Premaitha signs European deals

Premaitha Health has signed two new service contracts with customers in Armenia and Moldova for its IONA test – the non-invasive prenatal screening test (NIPT) for Down’s Syndrome on pregnant women.

The company has already signed distribution deals for IONA to laboratories in France and Greece.

Premaitha chief executive Dr Stephen Little said: “We are pleased to see our international footprint increase as demand for NIPT using the IONA test grows. The high clinical standards and excellent customer support offered by Premaitha’s screening services team, coupled with the proven performance of the IONA test means that we are able to provide pregnant women with the best possible screening test.”


See the article in full at

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.